Targeted therapies for RET-fusion cancer: Dilemmas and breakthrough
2020 · Biomedicine & Pharmacotherapy · 5 citations
https://doi.org/10.1016/j.biopha.2020.110901
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
669
Citations
10
h-index
11
i10-index
Shunli Peng is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & MicroRNA in disease regulation & Cancer-related molecular mechanisms research. The author has an h-index of 10, co-authored 22 publications.
https://doi.org/10.1016/j.biopha.2020.110901
https://doi.org/10.1186/s13014-021-01898-z
Click to start Chat